Table 3.
Stage I (n = 533) | Stage II (n = 76) | Stage III (n = 25) | Stage IV (n = 3) | ||
---|---|---|---|---|---|
Variable | Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | p Value |
Age, y | 33.31 ± 8.09 | 33.79 ± 7.37 | 32.72 ± 8.85 | 28.33 ± 2.89 | 0.710 |
Time to onset d | 1.34 ± 1.86 | 1.22 ± 0.81 | 1.48 ± 1.12 | 3 ± 1.73 | 0.579 |
Time to resolution, d | 7.7 ± 7.59 | 9.62 ± 5.62 | 8.72 ± 5.21 | 10.67 ± 2.31 | 0.063 |
n | n | n | n | ||
Gender [M/F] | 298/235 | 43/33 | 12/13 | 2/1 | 0.854 |
Affected Eye [OD/OS] | 277/256 | 39/37 | 11/14 | 1/2 | 0.830 |
n | n | n | n | ||
AMO iFs | 435 | 66 | 24 | 3 | 0.637 |
WL FS200 | 59 | 6 | 0 | 0 | 1 |
Zeiss VisuMax | 39 | 4 | 1 | 0 | 1 |
DLK—diffuse lamellar keratitis; OD—right eye; OS—left eye; M—male; F—female; y—years; d—days.